A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease
Crossref DOI link: https://doi.org/10.1007/s13277-016-5024-z
Published Online: 2016-04-14
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kumar, J. Kiran
Aronsson, A. C.
Pilko, G.
Zupan, M.
Kumer, K.
Fabjan, T.
Osredkar, J.
Eriksson, S.
Funding for this research was provided by:
Swedish Research Council for Health, Working Life and Welfare
License valid from 2016-04-14